Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Torcetrapib

    Client Email Product

    Torcetrapib

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    0

    US DMFs Filed

    US DMFs Filed

    0

    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    0

    API REF. PRICE (USD / KG)

    0

    API Market Place

    0

    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    4
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    Pharma Failures Actually Advance Medicine
    Pharma Failures Actually Advance Medicine

    https://www.forbes.com/sites/johnlamattina/2018/10/16/pharma-failures-actually-advance-medicine/#200de8ad6105

    John LaMattina FORBES
    16 Oct 2018
    Share Share
    New FDA Report Cites 22 Drugs That Passed PhII But Crashed and Burned in PhIII
    New FDA Report Cites 22 Drugs That Passed PhII But Crashed and Burned in PhIII

    http://www.biospace.com/News/new-fda-report-cites-22-drugs-that-passed-phase-ii/444652/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews

    Mark Terry BIOSPACE
    21 Jan 2017
    Share Share
    Merck seeks oasis in CETP inhibitor desert
    Merck seeks oasis in CETP inhibitor desert

    http://www.pmlive.com/pharma_news/merck_seeks_oasis_in_cetp_inhibitor_desert_868680

    Phil Taylor PHARMATIMES
    18 Nov 2015
    Share Share
    Amgen's Acquisition Of Dezima And CETP Drug Like Pfizer's '03 Buy Of Esperion. Will History Repeat?
    Amgen's Acquisition Of Dezima And CETP Drug Like Pfizer's '03 Buy Of Esperion. Will History Repeat?

    http://www.forbes.com/sites/johnlamattina/2015/09/17/amgens-acquisition-of-dezima-and-cetp-drug-like-pfizers-03-buy-of-esperion-will-history-repeat/?ss=pharma-healthcare

    John LaMattina FORBES
    18 Sep 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-2024-05-06

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search